Home
Emergent BioSolutions EBS paid Capitol Counsel $50K for lobbying in Q1 2026 · Health Issues
Trade details
- Type
- Lobbying report
- Amount
- $50,000
- Quarter
- Q1 2026
- Client
- Emergent Biosolutions
- Reported
- 26/04/15
Up 0.0% from last quarter
What else happened in Emergent BioSolutions around then
Filed or reported within 30 days of the trade day · 03/01~04/30Emergent Biosolutions's other lobbying reports
- Emergent Biosolutions
LobbyingEmergent BioSolutions
LobbyingEmergent BioSolutions
EBS
$70K
$70K
Reported 07/19
for Q2
- Emergent Biosolutions
LobbyingEmergent BioSolutions
LobbyingEmergent BioSolutions
EBS
$40K
$40K
Reported 07/15
for Q2
- Emergent Biosolutions
LobbyingEmergent BioSolutions
LobbyingEmergent BioSolutions
EBS
$510K
$510K
Reported 07/14
for Q2
- Emergent Biosolutions
LobbyingEmergent BioSolutions
LobbyingEmergent BioSolutions
EBS
$50K
$50K
Reported 07/08
for Q2
- Emergent Biosolutions
LobbyingEmergent BioSolutions
LobbyingEmergent BioSolutions
EBS
$70K
$70K
Reported 04/20
for Q1